0001213900-18-014061.txt : 20181017 0001213900-18-014061.hdr.sgml : 20181017 20181017200948 ACCESSION NUMBER: 0001213900-18-014061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181017 DATE AS OF CHANGE: 20181017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson Mark E. CENTRAL INDEX KEY: 0001486558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 181127422 MAIL ADDRESS: STREET 1: 3031 TISCH WAY STREET 2: SUITE 505 CITY: SAN JOSE STATE: CA ZIP: 95128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2018-10-17 0 0000812796 SOLIGENIX, INC. SNGX 0001486558 Pearson Mark E. 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 1 0 0 0 Common Stock 2018-10-17 4 P 0 170000 1.16 A 2500000 D This transaction was executed in multiple trades at prices ranging from $1.14 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Mark E. Pearson 2018-10-17